FDA Inspection 989585 — Aurigene Pharmaceutical Services Limited

Aurigene Pharmaceutical Services Limited — FEI 3017399055

The FDA completed an inspection of Aurigene Pharmaceutical Services Limited on June 15, 2016 in Hyderabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hyderabad (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed